person · Reporting owner

READ IAN C

Disclosed activity across 6 companies

Tapewire entity: 15999
SEC CIK: 0001372915

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
DXC Technology CoDXC · Entity 4594	Director	August 20, 2021	August 24, 2021
Empery Digital Inc.VLCN · Entity 21	Director	July 17, 2025	July 21, 2025
KIMBERLY CLARK CORPKMB · Entity 3103	Director	January 03, 2022	January 05, 2022
PFIZER INCPFE · Entity 2863	Director · Executive Chairman	March 04, 2019	March 06, 2019
Population Health Investment Co., Inc.PHIC · Entity 136038	Director · Executive Chairman	November 17, 2020	November 17, 2020
Viatris IncVTRS · Entity 3277	Director	March 21, 2022	March 23, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DXC Technology Co

Report date August 20, 2021 · Filed August 24, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	48,800	Reported balance After 2021-08-20 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2021-08-20 · Grant · Acquired 12,700 · Balance 48,800 F1: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2: Amount reported includes unvested RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director.

F2: Amount reported includes unvested RSUs.

Empery Digital Inc.

Report date July 17, 2025 · Filed July 21, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnote	30,000	Reported balance After 2025-07-21 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2025-07-21 · Grant · Acquired 30,000 · Balance 30,000 F1: The shares of common stock were purchased by the Reporting Person in the Issuer's recently announced private placement with certain accredited and institutional investors, which closed on July 21, 2025. F2: The shares of common stock were purchased by the Ian Charles Read Revocable Trust the ("Trust"). The Reporting Person is the trustee of the trust and may be deemed to have sole voting and dispositive power over the shares held by the Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2035-07-17	Direct	298,802	Reported balance After 2025-07-17 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2025-07-17 · Grant · Acquired 298,802 · Balance 298,802 F3: The stock options vest based upon the daily volume weighted average price ("VWAP") of the Issuer's common stock, vesting as to 20% of the underlying shares of common stock upon the VWAP reaching $10 and then in incremental 20% installments until becoming fully vested upon a VWAP of $30. All vesting is subject to the approval by the Issuer's stockholder of a new stock option plan.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of common stock were purchased by the Reporting Person in the Issuer's recently announced private placement with certain accredited and institutional investors, which closed on July 21, 2025.

F2: The shares of common stock were purchased by the Ian Charles Read Revocable Trust the ("Trust"). The Reporting Person is the trustee of the trust and may be deemed to have sole voting and dispositive power over the shares held by the Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

F3: The stock options vest based upon the daily volume weighted average price ("VWAP") of the Issuer's common stock, vesting as to 20% of the underlying shares of common stock upon the VWAP reaching $10 and then in incremental 20% installments until becoming fully vested upon a VWAP of $30. All vesting is subject to the approval by the Issuer's stockholder of a new stock option plan.

KIMBERLY CLARK CORP

Report date January 03, 2022 · Filed January 05, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Share UnitsSEC Table II · derivative / convertible security	Direct	37,206	Reported balance After 2022-01-03 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2022-01-03 · Grant · Acquired 1,299 · Balance 37,206 F1: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F2: Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F2: Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock.

PFIZER INC

Report date March 04, 2019 · Filed March 06, 2019

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,109,202	Ending reported balance After 2019-03-04 transaction · row 26 26 source rows · reconciled sequence Row 1 · 2019-03-04 · Sale · Disposed 3,722 · Balance 1,635,558 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 2 · 2019-03-04 · Sale · Disposed 4,258 · Balance 1,631,300 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 3 · 2019-03-04 · Sale · Disposed 4,392 · Balance 1,626,908 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 4 · 2019-03-04 · Sale · Disposed 4,489 · Balance 1,622,419 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 5 · 2019-03-04 · Sale · Disposed 5,812 · Balance 1,616,607 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 6 · 2019-03-04 · Sale · Disposed 6,284 · Balance 1,610,323 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 7 · 2019-03-04 · Sale · Disposed 6,960 · Balance 1,603,363 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 8 · 2019-03-04 · Sale · Disposed 7,584 · Balance 1,595,779 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 9 · 2019-03-04 · Sale · Disposed 8,427 · Balance 1,587,352 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 10 · 2019-03-04 · Sale · Disposed 10,725 · Balance 1,576,627 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 11 · 2019-03-04 · Sale · Disposed 11,804 · Balance 1,564,823 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 12 · 2019-03-04 · Sale · Disposed 11,908 · Balance 1,552,915 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 13 · 2019-03-04 · Sale · Disposed 12,457 · Balance 1,540,458 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 14 · 2019-03-04 · Sale · Disposed 12,623 · Balance 1,527,835 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 15 · 2019-03-04 · Sale · Disposed 12,787 · Balance 1,515,048 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 16 · 2019-03-04 · Sale · Disposed 12,971 · Balance 1,502,077 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 17 · 2019-03-04 · Sale · Disposed 13,275 · Balance 1,488,802 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 18 · 2019-03-04 · Sale · Disposed 14,739 · Balance 1,474,063 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 19 · 2019-03-04 · Sale · Disposed 16,537 · Balance 1,457,526 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 20 · 2019-03-04 · Sale · Disposed 21,624 · Balance 1,435,902 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 21 · 2019-03-04 · Sale · Disposed 28,599 · Balance 1,407,303 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 22 · 2019-03-04 · Sale · Disposed 34,216 · Balance 1,373,087 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 23 · 2019-03-04 · Sale · Disposed 52,878 · Balance 1,320,209 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 24 · 2019-03-04 · Sale · Disposed 69,362 · Balance 1,250,847 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 25 · 2019-03-04 · Sale · Disposed 69,433 · Balance 1,181,414 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 26 · 2019-03-04 · Sale · Disposed 72,212 · Balance 1,109,202 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018.
Common StockSEC Table I · non-derivative	IndirectBy Rule 16b-3 Plan	11,442	Reported balance Holding disclosure · report date 2019-03-04 · row 27 Holding and transaction disclosures are not merged. 1 source row Row 27 · Balance 11,442

Filing footnotes · ownership attribution and instrument terms

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018.

Population Health Investment Co., Inc.

Report date November 17, 2020 · Filed November 17, 2020

This filing explicitly reported no securities owned.

Viatris Inc

Report date March 21, 2022 · Filed March 23, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	14,497	Reported balance After 2022-03-21 transaction · row 1 1 source row Row 1 · 2022-03-21 · Exercise / conversion · Acquired 166 · Balance 14,497 F1: Fractional shares have been rounded up in connection with the settlement described in footnote 2 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
Dividend Equivalent UnitsSEC Table II · derivative / convertible security	Direct	165.5224	Reported balance After 2022-03-21 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-03-21 · Grant · Acquired 165.5224 · Balance 165.5224 F2: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.
Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2022-03-21 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2022-03-21 · Exercise / conversion · Disposed 165.5224 · Balance 0 F2: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.

Filing footnotes · ownership attribution and instrument terms

F1: Fractional shares have been rounded up in connection with the settlement described in footnote 2 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.

F2: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 15, 2015 Filed May 18, 2015 22:14 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	138	$33.99	$4,690.62	Disclosure SEC source: 0001225208-15-012332 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,023 Underlying: Common Stock · 138 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
April 30, 2015 Filed May 1, 2015 21:05 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	138	$33.93	$4,682.34	Disclosure SEC source: 0001225208-15-010857 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,328 Underlying: Common Stock · 138 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
April 15, 2015 Filed Apr 16, 2015 21:31 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	126	$35.21	$4,436.46	Disclosure SEC source: 0001225208-15-010082 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,146 Underlying: Common Stock · 126 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
April 09, 2015 Filed Apr 14, 2015 01:02 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	4,100	$35.03	$143,623.00	Disclosure SEC source: 0001225208-15-009992 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,020 Underlying: Common Stock · 4,100 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
March 31, 2015 Filed Apr 1, 2015 22:21 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	131	$34.79	$4,557.49	Disclosure SEC source: 0001225208-15-009041 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,926 Underlying: Common Stock · 131 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
March 13, 2015 Filed Mar 17, 2015 16:41 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	5,423	$34.00	$184,382.00	Disclosure SEC source: 0001225208-15-008001 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,832 Underlying: Common Stock · 5,423 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	25,332	$34.58	$875,980.56	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 24 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,408,457 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	18,021	$34.57	$622,985.97	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 23 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,433,789 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	4,827	$34.59	$166,965.93	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 22 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,451,810 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	3,600	$34.75	$125,100.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 21 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,456,637 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	3,000	$34.74	$104,220.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 20 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,460,237 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	1,800	$34.73	$62,514.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 19 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,463,237 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	1,600	$34.76	$55,616.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 18 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,465,037 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	1,400	$34.77	$48,678.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 17 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,466,637 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	900	$34.72	$31,248.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 16 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,468,037 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	800	$34.69	$27,752.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 15 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,468,937 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	700	$34.60	$24,220.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 14 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,469,737 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	700	$34.70	$24,290.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 13 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,470,437 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	700	$34.71	$24,297.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 12 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,471,137 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	700	$34.79	$24,353.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 11 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,471,837 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	600	$34.64	$20,784.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 10 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,472,537 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	500	$34.67	$17,335.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 9 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,473,137 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	500	$34.78	$17,390.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 8 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,473,637 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	420	$34.61	$14,536.20	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 7 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,474,137 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	400	$34.68	$13,872.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 6 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,474,557 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	300	$34.62	$10,386.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 5 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,474,957 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	200	$34.63	$6,926.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 4 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475,257 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	200	$34.65	$6,930.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 3 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475,457 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	200	$34.66	$6,932.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475,657 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
March 05, 2015 Filed Mar 7, 2015 00:19 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	100	$34.81	$3,481.00	Disclosure SEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475,857 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document
February 27, 2015 Filed Mar 2, 2015 23:39 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	68	$34.32	$2,333.76	Disclosure SEC source: 0001225208-15-006384 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,409 Underlying: Common Stock · 68 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
February 26, 2015 Filed Feb 27, 2015 23:50 UTC	PFIZER INC PFE · Entity 2863	GrantStock Appreciation Rights · Derivative	402,685	$0.00 Strike: $34.59	$0.00	Disclosure SEC source: 0001225208-15-006203 · doc4.xml · derivative · entry 10 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,685 Underlying: Common Stock · 402,685 shares Expires 2022-02-26 F8 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F8 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document
February 26, 2015 Filed Feb 27, 2015 23:50 UTC	PFIZER INC PFE · Entity 2863	GrantStock Appreciation Rights · Derivative	483,092	$0.00 Strike: $34.59	$0.00	Disclosure SEC source: 0001225208-15-006203 · doc4.xml · derivative · entry 9 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,092 Underlying: Common Stock · 483,092 shares Expires 2020-02-26 F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document
February 25, 2015 Filed Feb 27, 2015 23:50 UTC	PFIZER INC PFE · Entity 2863	Exercise / conversionStock Appreciation Rights · Derivative	197,072	$0.00 Strike: $17.69	$0.00	Disclosure SEC source: 0001225208-15-006203 · doc4.xml · derivative · entry 8 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 197,072 shares Expires 2015-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 25, 2015 Filed Feb 27, 2015 23:50 UTC	PFIZER INC PFE · Entity 2863	Tax withholdingCommon Stock	77,662	$33.47	$2,599,347.14	Disclosure SEC source: 0001225208-15-006203 · doc4.xml · nonDerivative · entry 5 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475,957 F5 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F6 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document
February 25, 2015 Filed Feb 27, 2015 23:50 UTC	PFIZER INC PFE · Entity 2863	Tax withholdingCommon Stock	60,360	$34.66	$2,092,077.60	Disclosure SEC source: 0001225208-15-006203 · doc4.xml · nonDerivative · entry 4 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,553,619 F4 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document
February 25, 2015 Filed Feb 27, 2015 23:50 UTC	PFIZER INC PFE · Entity 2863	Tax withholdingCommon Stock	37,813	$34.66	$1,310,598.58	Disclosure SEC source: 0001225208-15-006203 · doc4.xml · nonDerivative · entry 3 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,613,979 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document
February 25, 2015 Filed Feb 27, 2015 23:50 UTC	PFIZER INC PFE · Entity 2863	GrantCommon Stock	83,074	$0.00	$0.00	Disclosure SEC source: 0001225208-15-006203 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,651,792 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document
February 25, 2015 Filed Feb 27, 2015 23:50 UTC	PFIZER INC PFE · Entity 2863	Exercise / conversionCommon Stock	197,072	$17.69	$3,486,203.68	Disclosure SEC source: 0001225208-15-006203 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,568,718 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document
January 13, 2015 Filed Jan 15, 2015 19:12 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	614	$32.44	$19,918.16	Disclosure SEC source: 0001225208-15-001398 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,946 Underlying: Common Stock · 614 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
December 31, 2014 Filed Jan 5, 2015 22:16 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	146	$31.15	$4,547.90	Disclosure SEC source: 0001225208-15-000530 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,332 Underlying: Common Stock · 146 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
December 15, 2014 Filed Dec 17, 2014 21:26 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	145	$30.86	$4,474.70	Disclosure SEC source: 0001225208-14-025336 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,219 Underlying: Common Stock · 145 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
November 26, 2014 Filed Nov 28, 2014 21:52 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	147	$31.10	$4,571.70	Disclosure SEC source: 0001225208-14-024102 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,074 Underlying: Common Stock · 147 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
November 14, 2014 Filed Nov 17, 2014 23:22 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	150	$30.34	$4,551.00	Disclosure SEC source: 0001225208-14-023446 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,991 Underlying: Common Stock · 150 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
October 31, 2014 Filed Nov 3, 2014 23:23 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	153	$29.95	$4,582.35	Disclosure SEC source: 0001225208-14-022489 · doc4.xml · derivative · entry 8 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,351 Underlying: Common Stock · 153 shares Expires not disclosed F6 · derivative.exercise_price: Each unit represents one phantom share of common stock. F7 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F7 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
October 30, 2014 Filed Nov 3, 2014 23:23 UTC	PFIZER INC PFE · Entity 2863	Exercise / conversionStock Appreciation Rights · Derivative	54,585	$0.00 Strike: $17.03	$0.00	Disclosure SEC source: 0001225208-14-022489 · doc4.xml · derivative · entry 7 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,585 shares Expires 2014-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
October 30, 2014 Filed Nov 3, 2014 23:23 UTC	PFIZER INC PFE · Entity 2863	SaleCommon Stock	67,500	$29.76	$2,008,800.00	Disclosure SEC source: 0001225208-14-022489 · doc4.xml · nonDerivative · entry 4 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,358,862 Read SEC document
October 30, 2014 Filed Nov 3, 2014 23:23 UTC	PFIZER INC PFE · Entity 2863	Tax withholdingCommon Stock	24,169	$28.75	$694,858.75	Disclosure SEC source: 0001225208-14-022489 · doc4.xml · nonDerivative · entry 3 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,426,362 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document
October 30, 2014 Filed Nov 3, 2014 23:23 UTC	PFIZER INC PFE · Entity 2863	Tax withholdingCommon Stock	15,375	$29.84	$458,790.00	Disclosure SEC source: 0001225208-14-022489 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,450,531 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document
October 30, 2014 Filed Nov 3, 2014 23:23 UTC	PFIZER INC PFE · Entity 2863	Exercise / conversionCommon Stock	54,585	$17.03	$929,582.55	Disclosure SEC source: 0001225208-14-022489 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,465,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.